0
0

Medical Supply Chain Security Act

2/8/2022, 11:22 PM

Congressional Summary of S 3343

Medical Supply Chain Security Act

This bill requires manufacturers of essential medical devices (i.e., those that are life supporting, life-sustaining, or intended for use for a debilitating disease or condition) to notify the Food and Drug Administration (FDA) if the device is discontinued or if there is any meaningful disruption to the device's manufacturing. The bill also authorizes the FDA to expedite review of such a device to mitigate or prevent a shortage.

Current Status of Bill S 3343

Bill S 3343 is currently in the status of Bill Introduced since February 27, 2020. Bill S 3343 was introduced during Congress 116 and was introduced to the Senate on February 27, 2020.  Bill S 3343's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of February 27, 2020

Bipartisan Support of Bill S 3343

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 3343

Primary Policy Focus

Health

Potential Impact Areas

- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Health information and medical records
- Health technology, devices, supplies
- Manufacturing
- Prescription drugs

Alternate Title(s) of Bill S 3343

Medical Supply Chain Security Act
Medical Supply Chain Security Act
A bill to amend the Federal Food, Drug, and Cosmetic Act to provide enhanced security for the medical supply chain.

Comments